WebMay 05, 2024. $1.68. $1.56. -7.14%. Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change. WebEarnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization 251 broadway massapequa park ny 11762 WebAug 8, 2024 · CRISPR Therapeutics AG (CRSP) delivered earnings and revenue surprises of -7.62% and 96.27%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? WebAug 8, 2024 · CRISPR Therapeutics AG (CRSP) came out with a quarterly loss of $2.40 per share versus the Zacks Consensus Estimate of a loss of $2.23. This compares to earnings of $9.44 per share a year ago. 251 arlington street acton ma 01720 WebJul 29, 2024 · CRISPR Therapeutics AG CRSP shares are trading higher after the company reported Q2 earnings per share results of $9.44, up from $(1.30) year-over-year. 'We expect to report clinical data from our ... Web2 rows · Jul 30, 2024 · Zacks Equity Research. CRISPR Therapeutics AG CRSP reported second-quarter 2024 earnings per ... boxer dog with no tail WebAug 9, 2024 · Barclays says that CRISPR Therapeutics AG's CRSP Q2 FY22 earnings release was largely incremental, ... CRSP shares are down 6.32% at $76.25 during the market session on the last check Tuesday.

WebJul 27, 2024 · CRSP’s earnings surpassed expectations in two of the trailing four quarters and missed twice, the average surprise being 24.82%. In the last reported quarter, CRISPR Therapeutics witnessed a ... WebJul 29, 2024 · CRISPR Therapeutics (NASDAQ:CRSP): Q2 GAAP EPS of $9.44 beats by $5.59.Revenue of $900M (+2249900.0% Y/Y) beats by $483.55M. Collaboration revenue primarily consisted of the $900.0 million upfront ... boxer don't try WebMay 08, 2024. $48.01. $43.23. -9.96%. Earnings announcements can affect a stock’s price. This ... WebAug 9, 2024 · CRISPR Therapeutics AG CRSP reported second-quarter 2024 net loss per share of $2.40, wider than the Zacks Consensus Estimate of a loss of $2.23. The company had posted earnings of $9.44 per share ... boxer dog work full time WebMar 19, 2024 · Riley also issued estimates for The Arena Group’s Q1 2024 earnings at ($1.21) EPS, Q2 2024 earnings at ($0.87) EPS, Q3 2024 earnings at ($0.31) EPS and Q4 2024 earnings at $0.38 EPS. WebMar 16, 2024 · CRISPR Therapeutics (CRSP) Q2 Earnings & Sales Miss Estimates 08/09/22-8:05AM EST Zacks CRISPR Therapeutics AG (CRSP) Reports Q2 Loss, Misses Revenue Estimates boxer donaire next fight WebMar 28, 2024 · In the past 60 days, estimates for Certara’s 2024 earnings per share have increased from 46 cents to $1.24. During the same period, the earnings estimates per share for 2024 have risen from 54 ...

WebJul 30, 2024 · CRISPR Therapeutics AG (CRSP Quick Quote CRSP - Free Report) reported second-quarter 2024 earnings per share of $9.44, beating the Zacks Consensus … 2/51 caledonian street bexley nsw 2207 Web哪里可以找行业研究报告？三个皮匠报告网的最新栏目每日会更新大量报告，包括行业研究报告、市场调研报告、行业分析报告、外文报告、会议报告、招股书、白皮书、世界500强企业分析报告以及券商报告等内容的更新，通过最新栏目，大家可以快速找到自己想要的内容。 25/1 cameron street langford